Related Experiment Video

Updated: Aug 22, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Androgen deprivation therapy for prostate cancer: current status and future prospects

Hiroshi Miyamoto1, Edward M Messing, Chawnshang Chang

  • 1George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and the Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.

The Prostate
|September 25, 2004
PubMed

Insights

Hormonal therapy for advanced prostate cancer offers symptom relief but doesn't consistently improve survival. New strategies are needed to overcome resistance and improve outcomes for patients with androgen-independent disease.

Area of Science:

  • Oncology
  • Endocrinology
  • Urology

Background:

  • Androgens are key drivers in prostate cancer development and progression.
  • Hormonal therapies targeting androgen action are standard for advanced prostate cancer.
  • While initially effective, most patients develop resistance, leading to disease progression.

Purpose of the Study:

  • To evaluate the role of hormonal therapy in improving overall survival for advanced prostate cancer.
  • To discuss the benefits of androgen deprivation therapy in symptom palliation and quality of life.
  • To highlight the need for novel treatment strategies for androgen-independent prostate cancer.

Main Methods:

  • Review of existing literature on androgen ablation and androgen receptor blockade in prostate cancer treatment.
  • Analysis of clinical response rates and survival data associated with hormonal therapies.
  • Exploration of mechanisms underlying treatment resistance and disease progression.

Main Results:

  • Hormonal therapy provides significant clinical response in most advanced prostate cancer patients.
  • Most patients eventually develop resistance to hormonal therapy, impacting overall survival.
  • Androgen deprivation therapy improves symptom palliation and quality of life in advanced disease.

Conclusions:

  • The contribution of hormonal therapy to overall survival in advanced prostate cancer remains controversial.
  • Novel therapeutic strategies targeting molecular mechanisms are essential for overcoming resistance.
  • Developing treatments for androgen-independent prostate cancer is critical for improving patient survival.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...